Previous 10 | Next 10 |
22nd Century Group, Inc. (XXII) Q3 2021 Earnings Conference Call November 4, 2021 10:00 AM ET Company Participants Mei Kuo – Director-Communications and Investor Relations Jim Mish – Chief Executive Officer Mike Zercher – President and Chief Operating Officer John Franzin...
22nd Century (NASDAQ:XXII): Q3 GAAP EPS of -$0.06 misses by $0.02. Revenue of $7.81M (+6.8% Y/Y) misses by $0.5M. Shares +2.01% PM. Press Release Executing From a Strong Financial Position with Cash and Cash Equivalents of $55.2 Million as of September 30, 2021. Uplisted Common Shares to the ...
Meeting Held October 14 with Senior Level Staff at FDA Company’s Confidence in a Positive MRTP Application Outcome and Timing at Its Highest Level Monetizing Hemp/Cannabis Plant Lines and IP Beginning in the Fourth Quarter of 2021 Introduced Hops as the Third Plant-Base...
ABC, ABUS, ACIW, ADAP, AES, AHCO, AKBA, ALBO, ALE, APD, APTV, ARW, ASPS, ATNX, ATRA, ATRS, BCE, BDX, BLDR, BLI, BLL, BRG, BXRX, CARS, CCOI, CFX, CHH, CI, CLDT, CMRX, CNHI, CNP, CNQ, COMM, CPE, CS, CTXS, CWEN, CYBR, DBRG, DEN, DIN, DISH, DLX, DNB, DOCN, DUK, EPAM, ERJ, ESTE, EURN, EVA, FIS, FW...
22nd Century (NASDAQ:XXII) is scheduled to announce Q3 earnings results on Thursday, November 4th, before market open. The consensus EPS Estimate is -$0.04 and the consensus Revenue Estimate is $8.31M (+13.8% Y/Y). Seeking Alpha contributor Alan Sumler rated the company's stock as bullis...
BUFFALO, N.Y., Oct. 20, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science, will host a live webcast ...
BUFFALO, N.Y., Oct. 01, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading agricultural biotechnology and intellectual property company focused on improving health and wellness through plant science, today announced that the Company will participate in the upco...
BUFFALO, N.Y., Sept. 27, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading agricultural biotechnology and intellectual property company focused on improving health and wellness through plant science, today announced that the Company will participate in the fol...
Today I’ll analyze two cannabis companies, Sundial Growers (SNDL) and 22nd Century Group (XXII), to see which is currently a better buy. Cannabis stocks remain a popular choice among retail investors due to their potential to generate market-beating gains in the upcoming decade. T...
Up until recently, investors knew that plant biotechnology company 22nd Century Group (NASDAQ: XXII) was in both the tobacco and cannabis industries, plus another unnamed sector (which it initially alluded to last year). On Aug. 30, the company finally unveiled what that last busine...
News, Short Squeeze, Breakout and More Instantly...
22nd Century Group Inc Company Name:
XXII Stock Symbol:
NYSE Market:
22nd Century Group Inc Website:
Patented, Fully Water Dispersing, Biodegradable Solution for World's Most Littered Item Mocksville, North Carolina--(Newsfile Corp. - July 10, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announce...
Mocksville, North Carolina--(Newsfile Corp. - July 9, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a new agreement for full-scale commercial rollout of its VLN® reduced nicotine cont...
Mocksville, North Carolina--(Newsfile Corp. - June 25, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a $1.5 million reduction in its secured debt via a paydown of the GVB secured promissor...